BCRX vs V · rev $374.7M vs P/E 33, rev $40.00B
BioCryst Pharmaceuticals Inc (BCRX) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
BCRX currently screens at market cap $1.83B. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the BCRX and V stock pages for the full models.
Not investment advice.